Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling.
Published in Bone marrow transplantation
Published in Bone marrow transplantation
Published in Bone marrow transplantation
Published in Bone marrow transplantation
Published in Bone Marrow Transplantation
Published in Bone Marrow Transplantation
Published in Bone Marrow Transplantation
The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19. This pandemic poses unprecedented stress on the health care system including programs performing allogeneic and autologous hematopoietic cell transplantation (HCT) and cellular therapy such as with CAR T cells. Risk factors for severe diseas...
Published in Bone Marrow Transplantation
Published in Bone Marrow Transplantation
Published in Bone Marrow Transplantation
Despite the availability of several antiemetics, clinical findings show that control of chemotherapy-induced nausea and vomiting (CINV) continues to be a serious concern for hematological patients, mainly for those receiving multiple-day (MD) and high-dose (HD) chemotherapy (CT). For CINV prophylaxis, 5-hydroxytryptamine type-3 receptor antagonists...
Published in Bone marrow transplantation
Post-transplant cyclophosphamide (PTCy) has become a promising option after allo-SCT, but infections may be more common than in traditional protocols. We herein report 117 consecutive adults who received PTCy-based alloSCT in our hospital: HaploSCT (34%), MRD (19%), and VUD (47%), respectively. The 18-month incidence of severe bacterial, viral, and...